Reporter May 11 2012
Long live the therapeutic stem cells
May. 17, 2012—Enhancing stem cell survival is key to improving cell-based therapies for regenerative medicine, and a new drug could help.
New clue to ADHD
May. 15, 2012—A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD.
Perfect timing for sensory processing
May. 11, 2012—Identification of brain regions involved in processing sights and sounds may offer insights into disorders like autism and dyslexia.
Probing epilepsy’s molecular sparks
May. 10, 2012—Understanding how mutations in neuronal receptors contribute to epilepsy could lead to improved therapies.
